Related Experiment Videos
Caffeine acetylator phenotyping during maturation in infants.
A Pariente-Khayat1, G Pons, E Rey
1Département de Pharmacologie Périnatale et Pédiatrique, Hôpital Saint-Vincent de Paul, Paris, France.
Pediatric Research
|May 1, 1991
Summary
Caffeine metabolism in children matures with age, with slow acetylator phenotypes common in infants. This study tracked caffeine acetylator phenotypes in children, finding a significant increase in fast acetylators as they age.
Area of Science:
- Pharmacology
- Pediatrics
- Biochemistry
Background:
- Caffeine acetylator phenotype influences drug metabolism.
- Understanding pediatric drug metabolism is crucial for safe and effective treatment.
- Maturation of metabolic pathways in children can alter drug responses.
Purpose of the Study:
- To investigate the development of caffeine acetylator phenotype during childhood.
- To determine the age-related changes in caffeine metabolism in pediatric populations.
- To compare caffeine acetylation in healthy children and those with Pierre Robin syndrome.
Main Methods:
- Phenotyping caffeine acetylator status using urinary metabolite ratios (AFMU/1-methylxanthine and other metabolite ratios) via High-Performance Liquid Chromatography (HPLC).
- Studied 54 children (8-447 days) with minor illnesses and 5 children with Pierre Robin syndrome.
- Serial phenotyping was conducted in children with Pierre Robin syndrome receiving chronic caffeine therapy.
Main Results:
- All infants under 83 days were slow acetylators; older children exhibited both slow and fast acetylator phenotypes.
- Caffeine acetylation ratios significantly increased with age, indicating a maturing metabolic capacity.
- The proportion of fast acetylators increased with age, though a plateau was not reached by 15 months.
Conclusions:
- Caffeine acetylator phenotype undergoes significant maturation during infancy and early childhood.
- Age is a critical factor in determining caffeine metabolic capacity in children.
- Individual variations in maturation exist, with some children transitioning from slow to fast acetylators over time.